pharmaphorum

MAY 7, 2021

Reports are emerging that the UK may join other countries in imposing restrictions on the use of AstraZeneca’s COVID-19 vaccine in younger people, after a fresh look at the risks and benefits of the shot. . The Joint Committee on Vaccination and Immunisation (JCVI) said last month that it is preferable for adults aged under 30 with no underlying conditions to be offered an alternative to the AZ/Oxford University adenovirus-based vaccine where available.

Vaccines 130

Vaccines Hospitals 130

Outsourcing Pharma

MAY 3, 2021

On May 5, a panel of experienced industry experts will discuss recent developments during Innovations in Drug Delivery, a free one-hour industry webinar.

112

112

Pharma Mirror

MAY 6, 2021

Are you catching yourself turning the volume up when listening to the radio or watching a TV show? Have thought about what might be the reason behind that, or have you just assumed that it is perfectly normal and that there is absolutely no reason to worry about anything? If it’s the latter, then I suggest you think twice. The simple truth is that this can actually be a rather serious problem and even if it’s not, your decision to ignore it will most definitely make it serious.

52

52

Med Ed 101

MAY 5, 2021

The following case demonstrates the terbinafine amitriptyline interaction as well as another interaction you should be aware of! JS is a 63-year-old female. Past medical history includes hypertension, CHF, ASCVD, recent fungal infection, depression, insomnia, breast cancer, and neuropathy. Terbinafine 250 mg QD Omeprazole 20 mg QD Lisinopril 5 mg QD Carvedilol 6.25 mg BID […].

40

40

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

MAY 6, 2021

UK-based performance-io has added to its senior team through two promotions and the appointment of STEM Healthcare CEO Jason McKenna as a non-executive director. He will oversee the online performance marketing and digital benchmarking agency’s growth in the US joins Rob Wood and Barrie Brien on performance-io’s non-executive board. McKenna has been with STEM since 2010, founding it in the US and Brazil before taking over the CEO role from co-founder Rob Wood in 2018.

119

119

Outsourcing Pharma

MAY 3, 2021

According to a recent survey of executives conducted by CPhI, COVID-19âs impact is driving manufacturing and CDMOs are fueling industry growth.

102

102

Med Ed 101

MAY 2, 2021

There may be a new option on the horizon for current insulin users! Insulin icodec is a new insulin option currently undergoing clinical trials. The most recent trial released for insulin icodec came out in November of 2020. The trial looked at the new insulin icodec, which is a once-weekly insulin injection, with a time […]. The post Is Once-Weekly Insulin On The Way?

40

40

pharmaphorum

MAY 6, 2021

UK biotech Inspira Pharmaceuticals has emerged from stealth mode with a deal with Vectura to develop an inhaled therapy for COVID-19 that could be ready for human testing within 12 months. . The start-up is focusing on processed and purified extracts from an undisclosed plant source that have been shown in lab studies to kill the SARS-CoV-2 virus, and also have potential applications in other respiratory infections.

Vaccines 111

Vaccines 111

Outsourcing Pharma

MAY 6, 2021

This monthâs roundup of new hires, investment funding, partnerships, and other industry news includes key firms such as Clinical Ink, Medable, CPhI, and Sterling Pharma.

55

55

Pharma Mirror

MAY 6, 2021

If someone told you that they could hear music in their ears while stimulated by absolutely no melodies in the real world, you might think it to be cool. It’s like you always have your very own, private party. If that’s what you would think about it, though, then it means that you haven’t actually thought about it seriously and that you haven’t taken into account how scary this can be for most people, especially when they become aware of it for the first time.

52

52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharma Times

MAY 4, 2021

Cilta-cel is an investigational CAR-T cell therapy for the treatment of relapsed/refractory multiple myeloma

58

58

pharmaphorum

MAY 4, 2021

The life sciences history industry has some unique challenges when it comes to compliance. But if you think third party compliance risks are bad, don’t take your eye off fourth and fifth parties, says Allan Matheson. Early life science pioneers in foreign markets earned a reputation for lax ethical behaviour, making them a prime target for regulators.

Documentation 111

Documentation Pharmaceutical Companies Pharmaceutical Companies Hospitals 111

Outsourcing Pharma

MAY 3, 2021

A leader from the mobile research nursing specialist offers advice on what to look for in a service provider, and why finding the right one is vital.

59

59

Druggist

MAY 6, 2021

Metformin is the most commonly prescribed medication for the treatment of diabetes in the UK. It is also one of the most prescribed drugs overall in the UK. As with other drugs, it is possible to experience side effects during the treament or medicine may not be suitable. Metformin can commonly cause gastrointestinal side effects and this very often leads to switching to another drug.

Documentation 98

Documentation 98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharma Times

MAY 7, 2021

Decision brings the innovative treatment to early-stage lung cancer patients, helping to address unmet need in this setting

52

52

pharmaphorum

MAY 5, 2021

A medicine based on MDMA – the active ingredient in recreational drug ecstasy – is on the cusp of FDA approval as a treatment for post-traumatic stress disorder (PTSD), according to the organisation developing it. . The non-profit Multidisciplinary Association of Psychedelic Studies (MAPS) is leading the development of MDMA and has just reported top-line results from a phase 3 trial of the drug combined with psychotherapy that it says could form the basis of a marketing application to the US reg

FDA 111

FDA Compounding 111

Outsourcing Pharma

MAY 6, 2021

In the face of increasing demand for decentralized clinical trials and remote technology, the company has received funding to enable its further expansion.

52

52

Fuld

MAY 3, 2021

Sales acceleration is a form of competitive intelligence (CI) in the sales enablement ecosystem. An effective accelerated sales strategy arms your business with timely data and insights that ramp up the velocity and relevance of sales conversations. With the right up-front research, your product positioning will be calibrated with market demand, your sales cycle will get more efficient, your pipeline will speed up, and your reps will gain the strategic clarity and tools to help them win.

111

111

Pharma Times

MAY 6, 2021

The cost regulator has rejecting funding the drug as maintenance treatment of advanced/metastatic urothelial cancer

50

50

pharmaphorum

MAY 5, 2021

Pfizer expects revenues from its BioNTech-partnered COVID-19 vaccine to reach an eye-watering $26 billion this year, catapulting it to the top of the world’s biggest-selling medicines. . The company also said that it doesn’t expect the massive sales to be a one-off, as demand from governments around the world for coronavirus vaccines will continue to be strong in the coming years.

Vaccines 105

Vaccines Pharmaceutical Companies Pharmaceutical Companies FDA 105

Outsourcing Pharma

MAY 6, 2021

The head of small-molecule business for the pharma solutions specialist talks about obstacles, and how companies can work to clear them for future success.

52

52

Lifewell Rx Pharmacy

MAY 4, 2021

Medication adherence plays a significant role in keeping you on top of your treatment plan and ultimately recovering. However, taking your medication is not always a straightforward process due to side effects, physical limitations, provider issues, prohibitive costs, and even time management. We know these challenges all too well as a community pharmacy in Kentucky at LIFEWELL RX PHARMACY so we have made sure to devise ways to help patients adhere to their medications.

Packaging 52

Packaging Independent Pharmacies Community Pharmacies Labelling 52

Pharma Times

MAY 4, 2021

Targeting a specific mutation in the CUX1 gene may offer a ‘new therapy avenue’ for AML patients

49

49

pharmaphorum

MAY 6, 2021

UK biotech Silence Therapeutics has launched an online game to raise the profile of the rare blood disorder thalassaemia, and one of its most common symptoms. . Blood Run Beta can be played online at www.bloodrunbeta.game and has been launched in the build-up to International Thalassaemia Day on Saturday 8 May. It aims to help players learn more about the daily impact of thalassemia and in particular fatigue, which can have a significant impact on patients’ daily lives.

104

104

Outsourcing Pharma

MAY 4, 2021

A leader from the clinical development services provider recommends using industry modal values to avoid protocol amendments, enrollment problems and more.

52

52

pharmaphorum

MAY 7, 2021

Antoinette Bobbitt has been promoted to executive vice president, strategy director at independent US creative agency, The Bloc. As EVP, Strategy Director, Antoinette will be responsible for ensuring that the agency’s talent, planning methodology, and tools are aligned with the Bloc’s vision of building exceptional customer experiences. She will oversee the strategy for several clients, and she’ll manage a team that works across all business units in order to ensure The Bloc’s competitive differ

Vaccines 98

Vaccines 98

pharmaphorum

MAY 6, 2021

Shares in COVID-19 vaccine manufacturers have taken a hit after the US signalled its support for waiving patents on them, a moved aimed to boost global supplies of the life-saving shots. Waiving the patent on proprietary knowledge would allow it to be shared with other manufacturers and the matter is being discussed by the World Trade Organization’s General Council today.

Vaccines 98

Vaccines 98

pharmaphorum

MAY 4, 2021

AstraZeneca is already seeing sales rocket for its SGLT2 inhibitor Farxiga in heart failure, and is expected to gather even more momentum after claiming FDA approval in chronic kidney disease (CKD). . The US regulator has cleared Farxiga (dapagliflozin) to reduce the risk of kidney damage, end-stage kidney disease, cardiovascular, death and hospitalisation for heart failure in adults with CKD who are at risk of progression.

FDA 98

FDA Labelling 98

pharmaphorum

MAY 7, 2021

UK-based Small Pharma has launched on the Toronto’s TSX Venture Exchange, raising 58 million Canadian dollars (around £34m) to develop medicines based on N,N-dimethyltriptylene (DMT) to treat depression. Small Pharma is following the trend for development of psychedelic medicines, a field where research has been suppressed for years because of legal restrictions on use of these compounds in many countries.

Compounding 98

Compounding 98

pharmaphorum

MAY 5, 2021

Roche’s cancer immunotherapy Tecentriq has been granted a new use by European regulators, for the first-line treatment of certain patients with metastatic non-small cell lung cancer (NSCLC). Tecentriq (atezolizumab) has now been used in Europe for adults with metastatic NSCLC whose tumours have high PD-L1 expression. The tumours must also have no epidermal growth factor receptor (EGFR) or anaplastic lymphoma kinase (ALK) mutations.

Chemotherapy 98

Chemotherapy FDA 98

pharmaphorum

MAY 4, 2021

COVID-19 has massively accelerated the uptake of digital health technology across the whole ecosystem, with important implications for pharma, medical device and insurance tech companies. The key trends for these sectors are identified and analysed in a new white paper from Healthware Group that offers guidance on how companies can best adjust to the new digital scenario.

Insurance 98

Insurance 98

pharmaphorum

MAY 4, 2021

Rare disease specialist Vicore Pharma has signed an agreement with Alex Therapeutics to test a digital therapeutic designed to provide cognitive behavioural therapy support to patients with the lung scarring disease idiopathic pulmonary fibrosis (IPF). The agreement allows for a clinical development programme for Vicore’s digital therapeutic (DTx) VP04.

84

84

pharmaphorum

MAY 5, 2021

After an indifferent period Novo Nordisk has kicked off 2021 on the front foot, raising its financial forecast after posting better than expected Q1 earnings and sales. The world’s biggest manufacturer of diabetes drugs expects growth in constant currencies at between 6% and 10%, up from the previous forecast in the 5%-9% range. Operating profit is expected to be in constant currencies in the 5% to 9% range, up from the previous estimate of 4%-8%.

Labelling 72

Labelling FDA 72

pharmaphorum

MAY 6, 2021

A new drug discovery firm, Eikon Therapeutics, has launched with former Merck & Co research chief Roger Perlmutter at the helm. Eikon is backed with $148 million in Series A financing led by The Column Group, with Foresite Capital, Innovation Endeavors and Lux Capital also joining. The California-based company said it aims to use super-resolution microscopy, based on advanced optics and machine learning techniques, to study the behaviour of proteins in live cells.

Research Laboratories 64

Research Laboratories 64